Labcorp Holdings Inc. (FRA:N6B)

Market Cap	16.81B
Revenue (ttm)	12.57B
Net Income (ttm)	720.56M
Shares Out	n/a
EPS (ttm)	8.54
PE Ratio	23.33
Forward PE	n/a
Dividend	2.68 (1.34%)
Ex-Dividend Date	May 29, 2025

Volume	85
Average Volume	18
Open	200.00
Previous Close	195.00
Day's Range	200.00 - 200.00
52-Week Range	175.50 - 240.00
Beta	n/a
RSI	46.41
Earnings Date	Apr 29, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical Laboratories
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N6B

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD